Tissue and plasma-based highly sensitive blocker displacement amplicon nanopore sequencing for EGFR mutations in lung cancer
- Home
- Resource Centre
- Tissue and plasma-based highly sensitive blocker displacement amplicon nanopore sequencing for EGFR mutations in lung cancer